Kenneth A. Clark
Director · Summit Therapeutics Inc.
Individual
- 2024
- Oct 15, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kenneth A. Clark files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- Yu Xia - $10.00M in SMMT purchases and sales in the last 12 months
- Manmeet Singh Soni - $722K in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kenneth A. Clark?
Kenneth A. Clark is a corporate insider, tracked as Director of Summit Therapeutics Inc. (SMMT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kenneth A. Clark last file a Form 4?
The only primary Form 4 on record is dated 15 October 2024.